Please be aware that all information shared here at Canada Pharmacy has been medically reviewed and fact-checked for accuracy. These verifications are made by board-certified medical professionals who have the authority required to state that information related to medical conditions, symptoms, procedures and tests, and standard treatment protocols is valid and truthful. This is based on current guidelines and consensuses shared amongst medical professionals, and in representation of the latest research.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
TOUJEO (insulin glargine) is prescribed to treat high blood sugar (hyperglycemia) in people with diabetes mellitus.
TOUJEO insulin is a long-acting insulin that is administered once daily, and its effects work for about 24 hours in most people.
Compared to other long-acting insulin products, TOUJEO has a higher concentration of 300 units per milliliter. The higher concentration means that people who inject large amounts of insulin can inject the same amount of medication in a lower volume.
TOUJEO SOLOSTAR pens can hold up to 450 units of insulin (1.5 milliliters.)
Administer TOUJEO subcutaneously once-daily at the same time each day. Do not change the injection time without speaking to your doctor first.
Rotate injections sites between the abdomen, thighs, and back of the arm to help avoid lipodystrophy.
Monitor blood sugar closely when making any changes to an insulin regimen.
The active ingredient in TOUJEO is insulin glargine.
The following medications can change blood sugar, requiring that the dose of TOUJEO be adjusted:
Tell your doctor if you are taking any of the above.
Hypoglycemia is a common side effect of TOUJEO and other insulin products. The symptoms of hypoglycemia can include:
Read the label on the TOUJEO pen carefully before each injection. This helps to prevent medication errors.
While taking insulin, your doctor should monitor potassium levels, kidney function, and liver function.
Tell your doctor if you have a history of cardiovascular disease.
TOUJEO [package insert] Bridgewater, NJ: Sanofi-Aventis; 2015.